Long Term Results with the Second Generation Mitroflow Pericardial Valve

Isolated aortic (n=4), mitral (n=9), and double (n=1) valve replacements were performed with the Mitroflow pericardial valve in 14 patients from January to November in 1985. The mean age of these patients was 45.6 years. All patients were followed for a total of 85 patient-years (PY). There was one...

Full description

Saved in:
Bibliographic Details
Published inJinko Zoki Vol. 24; no. 2; pp. 443 - 447
Main Authors AKIYAMA, Kazuya, KAINUMA, Yasuhiro, NAKAJIMA, Takayuki, HIROTA, Jun, SHIINA, Yoshitaka, OKADO, Akihiko
Format Journal Article
LanguageJapanese
Published JAPANESE SOCIETY FOR ARTIFICIAL ORGANS 1995
一般社団法人 日本人工臓器学会
Subjects
Online AccessGet full text
ISSN0300-0818
1883-6097
DOI10.11392/jsao1972.24.443

Cover

More Information
Summary:Isolated aortic (n=4), mitral (n=9), and double (n=1) valve replacements were performed with the Mitroflow pericardial valve in 14 patients from January to November in 1985. The mean age of these patients was 45.6 years. All patients were followed for a total of 85 patient-years (PY). There was one operative, non-valve related death in the patient with double valve replacement. Valve-related complications included one anticoagulant-related hemorrhage (1.2% of PY). one non-structural valve deterioration (hemolytic anemia) (1.2% of PY), and ten structural deteriorations (12.9% of PY). Afetr 9 years, freedom from reoperation was 8.6±2.6%. We concluded that this second generation pericardial valve, the Mitroflow valve, provides inferior clinical performance compared to the porcine aortic valve and its use has to be discontinued.
ISSN:0300-0818
1883-6097
DOI:10.11392/jsao1972.24.443